Elmiron (pentosane polysulfate sodium) - Important Safety Information form bene-Arzneimittel GmbH as approved by the HPRA

Notice type: 3rd Party Publications

Date: 18/07/2019


 


Problem Or Issue:

Important Safety Information communication from bene-Arzneimittel GmbH on risk of pigmentary maculopathy of Elmiron (pentosane polysulfate sodium)

 

Important Safety Information - Elmiron (pentosane polysulfate sodium)




« Back